Related Experiment Video
Updated: Aug 22, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Genes transcriptionally modulated by interferon alpha2a correlate with the cytokine activity
Achille Iolascon1, Stefano Volinia, Adriana Borriello
1Medical Genetics University Federico II, Naples, Italy.
Background And Objectives:
Interferon alpha2a (IFNalpha2a) mediates important antiviral, antiproliferative and immunomodulatory responses and is employed in the treatment of human diseases, including chronic myelogenous leukemia. Here, we report the IFNalpha2a-dependent expression profiles of three malignant cell lines derived from liver, lymphocytes and muscle.
Design And Methods:
The experiments were performed in the presence of cycloheximide, thus our results exclusively reflect direct transcriptional modulation. The short exposure time i.e. 5 hours evidences only the early events, excluding the effects of complex phenotypic changes on the expression.
Results:
Our findings indicate that IFNalpha2a rapidly up-regulates the expression of STAT1, STAT2 and ISGF3G genes. This activity should result in the amplification of the cellular response to the cytokine. Moreover, IFNalpha2a directly modulates the expression of: (i) important transcriptional factors, e.g. IRF1 and IRF7 which control pivotal cellular events, and (ii) enzymes involved in the IFNalpha2a-dependent antiviral and apoptotic response. Interestingly, we showed that the cytokine induces transcriptional expression of Sjögren's syndrome antigen A1, a protein involved in several autoimmune diseases.
Interpretation And Conclusions:
The observed changes induced by IFNalpha2a could be related to the development of autoimmune syndromes observed during IFNalpha2a treatment. A number of genes transcriptionally regulated by the cytokine have been identified for the first time; these might represent additional effectors of IFNalpha2a activity.
Insights
Interferon alpha2a (IFNalpha2a) rapidly up-regulates key genes involved in cellular responses. This cytokine also influences genes linked to autoimmune diseases, offering new insights into its therapeutic effects and potential side effects.
Area of Science:
- Molecular biology
- Immunology
- Cellular biology
Background:
- Interferon alpha2a (IFNalpha2a) is a cytokine used to treat diseases like chronic myelogenous leukemia.
- It mediates antiviral, antiproliferative, and immunomodulatory responses.
Purpose of the Study:
- To investigate the IFNalpha2a-dependent gene expression profiles in malignant liver, lymphocyte, and muscle cell lines.
- To identify early transcriptional events modulated by IFNalpha2a.
Main Methods:
- Experiments were conducted in the presence of cycloheximide to isolate direct transcriptional modulation.
- A short exposure time (5 hours) focused on early cellular events.
Main Results:
- IFNalpha2a rapidly up-regulated STAT1, STAT2, and ISGF3G gene expression, amplifying cellular response.
- Direct modulation of transcriptional factors (IRF1, IRF7) and enzymes involved in antiviral and apoptotic responses was observed.
- IFNalpha2a induced transcriptional expression of Sjögren's syndrome antigen A1, a protein implicated in autoimmune diseases.
Conclusions:
- Observed gene expression changes may relate to autoimmune syndromes associated with IFNalpha2a treatment.
- Novel genes transcriptionally regulated by IFNalpha2a were identified, potentially representing new effectors of its activity.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
General Transcription Factors
RNA Polymerase II Accessory Proteins
Master Transcription Regulators
Master Transcription Regulators
Co-activators and Co-repressors
